MANY COUNTRIES. ABOUT 60% OF ADULTS ARE overweight or obese in the United States.
were fed with high-fat food (Bio-Serv, Frenchtown, NJ; Product No. F3282) for 6 weeks to induce obesity, and fed with regular food again for additional 4 weeks to induce weight loss. In the high-fat food, fat, protein and carbohydrate provided 59.3%, 16 .2%, and 24.5% of calories, respectively. The weight gain only animals (n = 9) were fed with high-fat food for 10 weeks. Daily food intake was measured at weeks 0, 6, and 10. The regular lab chow and high-fat food provide 3.3 kcal/g and 5.29 kcal/g, respectively. The food intake data were converted into the total energy intake for statistical comparisons. The adjusted energy intake based on body mass was also calculated (adjusted energy intake = total energy intake [kcal]/body mass [gm] 0.568 ; the value of 0.568 has been used to calculate the metabolism against body mass in small mammals. 9 The EEG and EMG were further recorded at the end of the 6 th and 10 th weeks in all groups. The recording system consisted of a personal computer with an 12-bit analog-to-digital (AD) converter (Model PCI-6023E, National Instruments, Austin, TX), and a Grass Model 12 Neurodata amplifier system (Grass Instrument Division of Astro-Med, Inc., West Warwick, RI). The EEG and EMG signals were amplified with 12A5 amplifiers. The one-half cut-off frequencies in EEG recordings for low and high frequencies were at 0.5 and 35.0 Hz, respectively. The EMG signals were filtered with one-half cut-off for low and high frequencies at 100 and 10,000 Hz, respectively. The data collection was controlled by the computer and a computer program (SleepWave, developed in our lab). The J10 outputs from the 12A5 amplifiers were fed into the AD converter and displayed on the computer monitor. The EEG and EMG data were saved to the hard disk drive. The daily amounts of food intake were also measured during each recording period.
scoring of sleep data
Sleep-wake states were scored visually on a personal computer. The EEG and EMG records were scored as previously described.
6 Sequential 10-s segments of EEG, EMG, and the results of fast Fourier transformation (FFT) of EEG signals were graphically displayed in both condensed form (12-min data on the bottom of the screen) and expanded form (30-s data on the top of the screen) to provide both a good overview of the data and the details of EEG and EMG patterns. Sleep data were scored in 10-s segments. The vigilance states were defined according to the following criteria: NREMS was identified by high-voltage delta waves in the EEG and decreased muscle tone; REMS by predominant theta activity (6-10 Hz) in the EEG and absence of muscle tone with occasional muscle twitches; and wakefulness by low-voltage EEG activity, and increased and varying levels of muscle activities. The average number and duration of the episodes for each behavioral state were computed according to the scoring results. The criterion used was that each episode should last at least 30 s.
eeg Power spectrum analyses
The EEG data were subjected to off-line FFT. However, the EEG power alterations could not be compared between baseline and subsequent recordings in 2 of 9 animals in the weight gain/ loss group because EEG recorded at week 6 and week 10 was recorded from different EEG leads (due to the poor recording quality from the original EEG leads). Therefore, although the FFT signals were still useful by providing information in addition to EEG and EMG patterns for identifying sleep stages, these 2 animals were excluded from EEG power analyses. In the EEG power analyses, sequential 2 s of EEG data (256 samples) were treated with a Hanning window and the power spectrum data with 0.5 Hz resolution were obtained after FFT. The power spectrum data were averaged every 10 s to match the sleep scoring results. The data from NREM sleep were used to compute EEG slow wave activity (SWA). The total power from 0.5 to 4.0 Hz was calculated for each 10-s segment. The results were further averaged for each 3-h time block. Since power spectrum data are sensitive to subtle changes in EEG amplitude, the EEG SWA data were normalized using the average of EEG SWA across 24 h during the baseline (week 0) as 100 in each animal.
statistics
Two-way analysis of variance (ANOVA) for repeated measures was used to determine effects of weight gain and weight loss on sleep and EEG SWA. In the sleep analyses, the first independent variable was the treatment condition (comparisons between the baseline, week 6 and week 10), and the second independent variable was the time of day (light vs. dark). If significant differences were observed in the treatment condition or in the interaction between treatment conditions and time of day, Tukey multiple comparison procedures were used to compare individual differences between different time points. One way ANOVA was used to compared the differences in the body weight and energy intake. When the assumption of equal variance was violated, Friedman repeated measures ANOVA on ranks were used. A probability of ≤0.05 was considered statistically significant in all conditions.
results

Change in Body Weight and energy intake during high-Fat Feeding
The alterations of body weight and energy intake across the 10-week experimental period are shown in Table 1 . In the weight gain/loss group, high-fat food significantly increased the body weight by 32.57% compared to the baseline, whereas switching back to regular food reduced body weight to only 12.62% above the baseline (F 2,16 = 64.763, P < 0.001; week 6 vs. week 0, q 3,16 = 15.961, P < 0.001; week 6 vs. week 10, q 3,16 = 9.778, P < 0.001; week 10 vs. week 0, q 3,16 = 6.183, P = 0.001). In the weight gain only group, the body weight increased by 34.98% at week 6 and continued to increase to 54.18% above the baseline level at week 10 (F 2,16 = 140.397, P < 0.001; week 6 vs. week 0, q 3,16 = 15.088, P < 0.001; week 6 vs. week 10, q 3,16 = 8.282, P < 0.001; week 10 vs. week 0, q 3,16 = 23.370, P < 0.001). The control mice did not gain weight significantly at 6 weeks, but showed slight (4.49% above the baseline) but significant increases in their body weight at week 10 compared to the baseline and week 6 (F 2,10 = 18.079, P < 0.001; week 6 vs. week 0, q 3,10 = 1.123, not significant; week 6 vs. week 10, q 3,10 = 6.738, P < 0.002; week 10 vs. week 0, q 3,10 = 7.862, P < 0.001).
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In the weight gain/loss group, the amount of energy intake was significantly higher at week 6 compared to the baseline and week 10 (F 2,16 = 16.486, P < 0.001; week 6 vs. week 0, q 3,16 = 7.703, P = 0.001; week 6 vs. week 10, q 3,16 = 6.077, P = 0.002). The weight gain group showed similar pattern but the differences between week 6 and week 0 did not reach statistical significance (F 2,16 = 4.178, P < 0.025; week 6 vs. week 0, q 3,16 = 3.308, P = 0.079; week 6 vs. week 10, q 3,16 = 6.738, P < 0.025). Despite the fact that these animals were continuously fed with high-fat diet, their energy intake levels were reduced to the baseline level. In the meanwhile their body weight further increased significantly from week 6 to week 10. The control animals did not show clear change in energy intake across the experimental period.
The adjusted energy intake based on the body mass (kcal/ mass [gm] 0.568 /day) did not increase at week 6 compared to the baseline and was decreased in week 10 compared to week 6 in the weight gain/loss group (F 2,16 = 7.170, P = 0.006; week 6 vs. week 10, q 3,16 = 5.237, P = 0.005), and was significantly decreased at week 10 compared to both baseline and week 6 in the weight gain only group (χ² (2) = 10.667, P = 0.005; baseline vs. week 10, P < 0.05; week 6 vs. week 10, P < 0.05). The adjusted energy intake was not altered in the control group during the experimental period.
the amounts of Wakefulness and sleep
In the weight gain/loss group, the development of obesity and subsequent weight loss significantly altered the amounts of wakefulness, NREMS and REMS ( Figure 1 and Figure 2 ). Wakefulness was significantly reduced from 698.72 ± 13.58 min/day at baseline to 596.56 ± 13.24 min/day after weight gain and returned to 665.72 ± 18.01 min/day after weight loss (F 2,16 = 27.717, P < 0.001, main effect [treatment condition]): significant decrease at week 6 compared to the baseline (Tukey test: The 24-h patterns of wakefulness, NREMS, and REMS are displayed in 6-h blocks. In the weight gain/loss group, the weight gain (after 6 weeks feeding with high-fat food) decreased wakefulness and increased NREMS and REMS (left). These alterations returned to the baseline (week 0) at week 10 (after 4 weeks of refeeding with regular food). The control animals did not show significant alterations in the amounts of wakefulness, NREMS, and REMS (middle). In the weight gain only group (right), the amount of wakefulness was significantly decreased and the amount of NREM sleep was significantly increased at week 6 and week 10 compared to baseline. The time is expressed as minute/6 hours. The error bars indicate the standard error. The horizontal thick black bars above the abscissa indicate the dark period. In the weight gain/loss group, weight grain (after 6 weeks of highfat feeding) significantly decreased wakefulness, and increased NREMS and REMS compared to baseline (week 0) and weight loss at week 10 (after 4 weeks of refeeding with regular food): a, significant difference compared to baseline; b, significant difference from the weight loss. The control animals fed with regular food did not display significant alterations in sleep during the same experimental period. See text for details in statistical analyses. In the weight gain only group, the amount of wakefulness was significantly decreased and the amount of NREM sleep was significantly increased at week 6 and week 10 compared to the baseline.
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0.001, main effect [treatment condition]) compared to the baseline (q 2,16 = 6.703, P < 0.001) and to week 10 (q 2,16 = 4.947, P < 0.01). By week 10, the number of waking episodes was not significantly different from the baseline. The duration of waking episodes was significantly altered (F 2,16 = 11.509, P = 0.001, main effect [weeks]): significant decrease in week 6 compared to the baseline (q 2,16 = 6.783, P < 0.001 for 24-h period); and no significant change at week 10 compared to the baseline or week 6. The number of NREM sleep episodes were significantly increased after weight gain (F 2,16 = 6.582, P < 0.01; week 6 vs. week 0, q 2,16 = 4.921, P < 0.01; week 6 vs. week 10, q 2,10 = 1.201, P < 0.05; week 10 vs. week 0, q 2,10 = 3.720, P < 0.05), whereas the duration of NREMS episodes were not significantly altered (F 2,16 = 2.552, P = 0.109, main effect [treatment condition]). The number of REMS was significantly altered (F 2,16 = 2.211, P = 0.160), but post hoc comparisons did not reveal significant differences between specific group comparisons. The duration of REMS was not significantly altered during the experiment (F 2,16 = 0.0716, P = 0.931). The control group did not display a significant change in the number and duration of waking (number, F 2,10 = 1.628, P = 0.244; duration, F 2,10 = 2.033, P = 0.182), NREMS (number, F 2,10 = 1.667, P = 0.237; duration, F 2,10 = 2.693, P = 0.116) and REMS (number, F 2,10 = 0.234, P = 0.795; duration, F 2,10 = 1.050, P = 0.385) episodes during the same experimental period.
In the weight gain only group, the number waking episodes was slightly increased at week 10 compared to week 0 (F 2,16 = 3.898, P < 0.05, main effect; q 2,16 = 3.801, P < 0.05). The duration of waking episodes was significantly decreased after weight gain (F 2,16 = 10.016, P = 0.002; week 6 vs. week 0, q 2,16 = 4.733, P < 0.02; week 10 vs. week 0, q 2,16 = 6.006, P = 0.002). The number of NREMS episodes was significantly increased at week 10 compared to week 0 (F 2,16 = 3.898, P < 0.05, main effect; q 2,16 = 3.801, P < 0.05), whereas the duration of NREMS episodes was not significantly altered across the 10-week period (F 2,16 = 0.472, P = 0.632). The number and duration of REMS episodes were not significantly altered. There was a significant treatment condition and time of day interaction (F 2,16 = 9.973, P < 0.002). The amount of wakefulness was significantly less at week 6 than in week 0 (q 3,16 = 11.772, P < 0.001) and week 10 (q 3,16 = 7.069, P < 0.001) during the dark period. NREMS was also significantly different between treatment conditions (F 2,16 = 24.758, P < 0.005), but not during the light period. REMS was significantly increased after weight gain at week 6 and returned to baseline levels after weight loss at week 10 (F 2,16 = 12.971, P < 0.001; week 6 vs. week 0, q 3,16 = 6.697, P < 0.001; week 6 vs. week 10, q 3,16 = 5.646, P = 0.003; week 10 vs. week 0, q 3,16 = 1.051, P = 0.742, not significant). There was no significant interaction between treatment condition and time of day for REMS.
In contrast to the weight gain/loss group, the control mice fed with regular food did not show clear sleep alterations in the amounts of sleep and wakefulness (F 2,10 = 1.699, P = 0.237), NREMS (F 2,10 = 1.855, P = 0.206) and REMS (F 2,10 = 0.0226, P = 0.978) during the same periods.
Similar to the weight gain/loss group, the weight gain only group also displayed significant reduction of wakefulness and significant increases of NREM sleep at week 6 and week 10 compared to the baseline (Wakefulness: F 2,16 = 8.231, P < 0.003; week 6 vs. week 0, q 3,16 = 5.288, P = 0.005; week 10 vs. week 0, q 3,16 = 4.573, P < 0.02. NREMS: F 2,16 = 9.273, P < 0.002; week 6 vs. week 0, q 3,16 = 5.355, P < 0.005; week 10 vs. week 0, q 3,16 = 5.189, P = 0.006). There was no significant treatment and time of day interactions. The amount of REMS was slightly greater at week 6 compared to week 0 and week 10, but this trend was not significant (F 2,16 = 2.726, P = 0.096).
sleep structure: number and duration of sleep episodes
The number and duration of episodes for each behavioral state were further analyzed ( Table 2) .
In the weight gain/loss group, the number of waking episodes was significantly increased after weight gain (F 2,16 = 12.081, P < with our previous results that sleep alterations are associated with weight gain but not daily amounts of energy intake. That REMS in both weight gain/loss group and weight gain only group showed an increase at week 6 and a return to baseline line level at week 10 suggests that the increase of REMS is either transiently associated with DIO at a certain stage or is simply an acute effect of food intake.
Although sleep was consistently increased in DIO animals, both in the weight gain/weight loss group and the weight gain only group, some other aspects of sleep alterations were less consistent. For example, the increase of sleep and decrease of wakefulness were found only in the dark period in the weight gain/loss group, but distributed across a 24-h period in the weight gain only group in the present study and in our previous study. This difference could be due to individual differences and/or other unknown factors. Additional studies are needed to clarify what factors may influence the distribution of increased sleep across the light-dark cycle in DIO mice.
The increased number but not duration of NREMS episodes indicates lack of sleep fragmentation in the DIO mice, which is different from the ob/ob mice. 8 The reasons for this difference are unclear. A minor difference in methodology might contribute to this difference. The previous study on ob/ob mice used the minimal 20-s episode length in the calculation of duration of NREMS, whereas we used the minimal 30-s requirement in our studies as has been used in numerous other studies. Another possibility is that the development of sleep fragmentation may depend on the length and severity of DIO. Finally, it is possible that hypothalamic-pituitary-adrenal axis-mediated arousal 18 may be heightened in ob/ob mice since corticosterone levels are elevated in ob/ob mice 19 but not in DIO mice. 20 Regardeeg sWa EEG SWA was not significantly altered in any experimental group across the 10-week experimental period (Figure 1) . disCussion This is the first study to demonstrate that diet-induced weight loss in the obese animals is associated with normalization of sleep patterns. Previously, our group and others have observed that sleep is increased in DIO mice 6, 7 and ob/ob mice. 8 In the present study, we confirmed previous observations and further showed that DIO-induced sleep alterations are reversible by weight loss. The increased sleep along with the shorter and more frequent waking episodes in DIO mice are consistent with the observations in humans that obesity is associated with EDS, 3-5,10,11 whereas weight loss leads to improvement of sleep and sleepiness. [12] [13] [14] [15] [16] [17] Furthermore, the increase of sleep with weight gain and the subsequent decrease of sleep with weight loss cannot be explained by the recovery from surgery, the adaptation to the environment, or aging process, since the control animals fed with regular food did not display such sleep alterations during the same experimental period.
The increase of NREMS and the decrease of wakefulness reached significance by week 6 and remained stable throughout week 10 in DIO mice, even though the levels of total energy intake had returned to the baseline level and the adjusted energy intake (based on the body mass) had dropped below the baseline level by week 10. This observation suggests that the NREMS alterations associated with weight gain and loss cannot be explained by the acute effect of food intake, which is consistent less of the interpretation, the increase of sleep in the absence of evidence for sleep fragmentation in the DIO mice suggests that the increase of NREMS was not the result of poor sleep and strengthens the human data that obesity is a significant risk factor for EDS independent of night sleep disturbances. 3, 5 Our data also show that the EEG SWA was not altered during the weight gain period, indicating that the depth or intensity of sleep was not reduced in DIO mice. These observations further support that the increase of NREMS in DIO mice was not a compensatory response secondary to poor/shallow sleep.
The underlying mechanisms for the reversible sleep alterations are not known. Reduced levels of orexin, a wake-promoting peptide, 21 have been associated with obesity and EDS in narcolepsy. 22 Decreases of orexin in obese ob/ob mice 23 and db/ db mice 24 were observed in 2 studies, but not in another study. 25 However, high-fat diet increases orexin in the hypothalamus in both rats and mice, 26, 27 suggesting that the increase of NREMS reported here was not due to reduced orexin activities.
Obesity, both in humans and animals, is considered a state of low grade inflammation associated with peripheral increases of several sleep-promoting inflammatory cytokines such as interleukin-1beta (IL-1β), tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).
2, 28-32 IL-1β and TNF-α [33] [34] [35] are involved in physiologic sleep regulation. Exogenous IL-6 also induces sleep alterations in humans and rats, 36, 37 whereas endogenous IL-6 levels are altered by sleep-wake/light-dark cycles and sleep deprivation. 38, 39 Further, blood levels of TNF-α and IL-6 are elevated in disorders of EDS whereas neutralization of TNF-α is associated with decrease of sleepiness in obese humans. 2, 28, 40 The above reported studies suggest that these inflammatory cytokines may mediate the excessive sleep observed in DIO animals.
In summary, we have observed that sleep is increased by weight gain and decreased by subsequent weight loss in mice. EDS is a frequent complaint among obese patients and its reversal by weight loss may also improve daytime functioning and quality of life in obese patients.
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